Chemoradiotherapy of Newly Diagnosed Glioblastoma With Intensified Temozolomide
- 1 July 2010
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 77 (3), 670-676
- https://doi.org/10.1016/j.ijrobp.2009.05.031
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Efficacy and Tolerability of Temozolomide in an Alternating Weekly Regimen in Patients With Recurrent GliomaJournal of Clinical Oncology, 2007
- Is protracted low-dose temozolomide feasible in glioma patients?Neurology, 2006
- Temozolomide Combined with Irradiation as Postoperative Treatment of Primary Glioblastoma MultiformeStrahlentherapie und Onkologie, 2005
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaThe New England Journal of Medicine, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- MGMT: its role in cancer aetiology and cancer therapeuticsNature Reviews Cancer, 2004
- Enhancing Radiotherapy With Cyclooxygenase-2 Enzyme Inhibitors: A Rational Advance?JNCI Journal of the National Cancer Institute, 2003
- Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedulesBritish Journal of Cancer, 2003
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- Response criteria for phase II studies of supratentorial malignant glioma.Journal of Clinical Oncology, 1990